Pierre Mondoly
Overview
Explore the profile of Pierre Mondoly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quinonero C, Strik M, Catalan P, Mondoly P, Laborderie J, Haissaguerre M, et al.
Sensors (Basel)
. 2025 Feb;
25(3).
PMID: 39943295
Remote monitoring of pacemakers decreases patient complications and reduces public health expenses. The transmission of passive real-time electrograms (EGM) has been shown to increase the diagnostic yield, but this may...
2.
Echivard M, Sellal J, Ziliox C, Marijon E, Bordachar P, Ploux S, et al.
Eur Heart J
. 2024 Sep;
45(41):4428-4442.
PMID: 39299922
Background And Aims: Prophylactic implantable cardioverter-defibrillators (ICDs) are not recommended until left ventricular ejection fraction (LVEF) has been reassessed 40 to 90 days after an acute myocardial infarction. In the...
3.
Beneyto M, Rollin A, Bekouti J, Herviou N, Delasnerie H, Mondoly P, et al.
Heart Rhythm
. 2024 Aug;
22(1):277-279.
PMID: 39089564
No abstract available.
4.
de Guillebon M, Garcia R, Debeugny S, Bader H, Probst V, Bidegain N, et al.
Heart Rhythm
. 2024 May;
21(12):2530-2535.
PMID: 38810921
Background: Electrocardiographic screening before subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation is unsuccessful in around 10% of cases. A personalized screening method, by slightly moving the electrodes, to obtain a better R/T...
5.
Maury P, Sanchis K, Djouadi K, Cariou E, Delasnerie H, Boveda S, et al.
PLoS One
. 2024 Apr;
19(4):e0301753.
PMID: 38578782
Background: Atrial arrhythmias (AA) commonly affect patients with cardiac amyloidosis (CA) and are a contributing risk factor for the development of heart failure (HF). This study sought to investigate the...
6.
Marimpouy N, Guilbeau-Frugier C, Ferrieres J, Balen F, Ramirez A, Delmas C, et al.
Arch Cardiovasc Dis
. 2024 Mar;
117(4):244-248.
PMID: 38490843
Background: The true incidence of sudden death remains undetermined, with controversial results from various publications over time and countries. Aim: To investigate if different estimations would reach the values usually...
7.
Strik M, Ploux S, Eschalier R, Mondoly P, Fontagne L, Ramirez F, et al.
J Cardiovasc Dev Dis
. 2023 Oct;
10(10).
PMID: 37887877
Background: Implantable cardioverter-defibrillators (ICDs) need to reliably detect ventricular tachycardia (VT) and ventricular fibrillation (VF) while avoiding T-wave oversensing (TWOS), which is associated with a risk of inappropriate therapies. The...
8.
Cherbi M, Voglimacci-Stephanopoli Q, Delasnerie H, Mandel F, Domain G, Foltran D, et al.
Pacing Clin Electrophysiol
. 2023 Oct;
46(12):1546-1552.
PMID: 37885373
Background: Efficiency and safety of ablation using half normal saline (HNS) has been shown in refractory ventricular tachycardia (VT), but no evaluation in unselected larger populations has been made. Objective:...
9.
Waldmann V, Marquie C, Bessiere F, Perrot D, Anselme F, Badenco N, et al.
J Am Coll Cardiol
. 2023 Aug;
82(7):590-599.
PMID: 37558371
Background: Very few data have been published on the use of subcutaneous implantable cardioverter-defibrillators (S-ICDs) in patients with congenital heart disease (CHD). Objectives: The aim of this study was to...
10.
Strik M, Sacristan B, Bordachar P, Duchateau J, Eschalier R, Mondoly P, et al.
Heart Rhythm
. 2023 Jul;
20(10):1378-1384.
PMID: 37406873
Background: Pacemakers (PMs) and implantable cardioverter-defibrillators (ICDs) increasingly automatically record and remotely transmit nonsustained ventricular tachycardia (NSVT) episodes, which may reveal ventricular oversensing. Objectives: We aimed to develop and validate...